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Abstract
In obese humans, metabolism of glucocorticoids by
11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) and
A-ring reduction(by5a-and5b-reductases)isdysregulatedin
a tissue speciﬁc manner. These changes have been recapitu-
lated in leptin resistant obese Zucker rats but were not
observed in high-fat fed Wistar rats. Recent data from mouse
models suggest that such discrepancies may reﬂect differences
in leptin signalling. We therefore compared glucocorticoid
metabolism in murine models of leptin deﬁciency and
resistance. Male ob/ob and db/db mice and their respective
littermate controls (nZ10–12/group) were studied at the age
of 12 weeks. Enzyme activities and mRNA expression were
quantiﬁed in snap-frozen tissues. The patterns of altered
pathways of steroid metabolism in obesity were similar in
ob/ob and db/db mice. In liver, 5b-reductase activity and
mRNA were increased and 11b-HSD1 decreased in obese
mice,whereas5a-reductase1(5aR1)mRNAwasnotaltered.
In visceral adipose depots, 5b-reductase was not expressed,
11b-HSD1 activity was increased and 5aR1 mRNA was not
altered in obesity. By contrast, in subcutaneous adipose tissue
11b-HSD1 and 5aR1 mRNA were decreased. Systematic
differences were not found between ob/ob and db/db murine
modelsofobesity,suggestingthatvariationsinleptinsignalling
through the short splice variant of the Ob receptor do not
contribute to dysregulation of glucocorticoid metabolism.
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Introduction
Tissue-speciﬁcdysregulationoftheglucocorticoid-generating
enzyme 11b-hydroxysteroid dehydrogenase type 1 (11b-
HSD1) in rodent (Livingstone et al. 2000, Liu et al. 2003)
and human obesity (Bujalska et al. 1997, Fraser et al. 1999,
Rask et al. 2001) and the effects of 11b-HSD1 deﬁciency
(Morton et al. 2004) or inhibition (Alberts et al. 2002,
Hermanowski-Vosatka et al. 2005) to protect against obesity-
associatedmetabolicdysfunction,hassupportedthehypothesis
that variations in glucocorticoid metabolism within target
tissues play an important role in the pathophysiology of
Metabolic Syndrome.
In addition to 11b-HSD1, glucocorticoids are metabolised
by several other enzymes (Fig. 1). In liver, glucocorticoids are
inactivated by A-ring reductases (5a- and 5b-reductases and
3a-HSD) and regenerated by 11b-HSD1 (Andrew & Walker
2002). The pattern of metabolism in adipose tissue is similar,
with 5a-reductase 1 (5aR1), 3a-HSD and 11b-HSD1 being
expressed (Barat et al. 2007, Wake et al. 2007b). A-ring
reductases are also dysregulated in obesity. In human
obesity, whole body A-ring reduction is enhanced, as
judged by urinary steroid excretion, increasing peripheral
clearance of cortisol and (Andrew et al. 1998, Tomlinson et al.
2008) potentially inducing compensatory activation of the
hypothalamic–pituitary–adrenal axis (Andrew et al. 1998,
Rask et al. 2001, 2002). In leptin-resistant obese Zucker
rats increased urinary 5a-reduced metabolites can be
accounted for by up-regulation of expression and activities
of hepatic A-ring reductases (Livingstone et al. 2005). 5aR1 is
also expressed in adipose tissue but is not dysregulated in
subcutaneous (s.c.) adipose in obese humans or rats (Barat
et al. 2007, Wake et al. 2007b).
In studies of 11b-HSD1, up-regulation of enzyme
expression in adipose tissue and down-regulation in liver
has not been a universal ﬁnding in obesity. For example, in
diet-induced obesity in mice and rats adipose 11b-HSD1 is
down-regulated (Morton et al. 2004, Drake et al. 2005).
Furthermore, leptin resistant and deﬁcient mice have been
shown by Liu et al. to have divergent changes in hepatic
11b-HSD1 activity, with expression and activity being
decreased in leptin deﬁcient ob/ob mice (Liu et al. 2003)
but paradoxically increased in leptin resistant db/db mice (Liu
et al. 2005). These differences may reﬂect the distinctions
between the defects in leptin signalling in these models.
Leptin signals through several splice variants of the leptin
receptor (Ob-R; Lee et al. 1996) .T h el o n g - f o rmo ft h er e c e p t o r
(Ob-Rb) has an intracellular domain crucial to its signalling
properties via Stat3, and is predominantly expressed in the
hypothalamus, where it controls appetite regulation; this
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Sahai et al.2 0 0 4 ). A short form of the receptor lacking the
intracellular domain (Ob-Ra) is expressed in the liver
(Hoggard et al.1 9 9 7 ), where it can activate the inositol
trisphosphate kinase cascade, thus potentially modulating
insulin signalling pathways (Cohen et al.1 9 9 6 , Zhao et al.
2000). Stimulation of Ob-Ra may occur in db/db mice, but
not in ob/ob mice that lack circulating leptin. Indeed, Ob-Ra
activation may be critical in the development of hepatic
insulin resistance and non-alcoholic steatohepatitis (Sahai et al.
2004). It is possible that activation of Ob-Ra may be
responsible for leptin-induced up-regulation of 11b-HSD1
expression in hepatocytes (which lack Ob-Rb; Liu et al.
2005), and this mechanism may mediate up-regulation of liver
11b-HSD1 in db/db mice. This capacity for residual leptin
signalling in db/db mice is not predicted in Zucker obese rats,
since the fa mutation in the leptin receptor affects the
extracellular domains of both Ob-Ra and b (Chua et al.1 9 9 6 ,
Da Silva et al.1 9 9 8 ). We therefore hypothesised that deﬁcient
leptin signalling underlies dysregulation of hepatic glucocorti-
coid metabolism by 11b-HSD1 and A-ring reductases.
The aims of the present study were to explore glucocorti-
coid metabolism – not only by 11b-HSD1 but also by A-ring
reductases – in murine models of obesity and, by comparing
ﬁndings in ob/ob and db/db mice, to dissect the potential role
of Ob-Ra in mediating dysregulation of hepatic steroid
metabolism in obesity.
Materials and Methods
Materials
AllchemicalswereobtainedfromSigmaunlessotherwisestated.
Solvents were glass distilled HPLC grade from Fisher Sci-
entiﬁc (Loughborough, UK). Steroid standards were obtained
from Steraloids (Newport, RI, USA). Radiolabelled-steroids
were from GE Healthcare (Buckinghamshire, UK).
Animals
Male obese (Lepr
DB/Lepr
DB (db/db) and Lep
ob/Lep
ob (ob/ob))
mice and their respective lean heterozygote or wild-type
littermates (Db/? and Ob/?; C57BL background; Harlan,
Bicester, UK) were characterised by phenotype, maintained
under controlled conditions of light (on 0700–1900 h) and
temperature (21 8C), and allowed free access to standard chow
(Special Diet Services, Witham, UK) and drinking water.
At 12 weeks of age, they were decapitated at 0800–1100 h
and tissues dissected and snap frozen on dry ice. All animal
experiments were carried out under UK Home Ofﬁce
guidelines.
Biochemical assays
Glucose and insulin were measured by hexokinase (Thermo
Electron, Melbourne, Australia) and ELISA (Crystal Chem
Inc.,DownersGrove,IL,USA)respectively.Hepatictriglycer-
ides were measured spectrophotometrically (Microgenics,
Passau, Germany) as previously reported (Raubenheimer
et al. 2006). Corticosterone was quantiﬁed in plasma by
in-house RIA (Holmes et al. 1995).
11b-HSD1 activity assay
11b-HSD1 is a reductase in vivo, converting inactive
11-dehydrocorticosteronetocorticosterone.However,invitro
dehydrogenase activity predominates and measurements of
reductase activity are confounded by competition with other
enzymes. Therefore, to estimate 11b-HSD1 protein, we
measured enzyme activity as conversion of corticosterone to
11-dehydrocorticosterone in the presence of an excess of
cofactor NADP
C. Aliquots of tissues were homogenised
in Krebs Ringer buffer as previously described (Livingstone
et al. 2000), and protein concentrations determined color-
imetrically using a Bradford kit (Bio-Rad). Standardised
amounts of protein for each tissue were incubated in duplicate
at 37 8C in Krebs Ringer buffer containing 0.2% glucose,
NADP
C (2 mmol/l), [
3H]4-corticosterone (10 nmol/l) and
unlabelled corticosterone (1.99 mmol/l). Protein concen-
trations and incubation times were optimised for each
tissue to ensure ﬁrst order kinetics (liver, 25 mg/ml per
h; adipose tissue, 100–200 mg/ml per h). After incubation,
steroids were extracted with ethyl acetate, the organic phase
evaporated under nitrogen and extracts re-solubilised in
mobile phase (water:acetonitrile:methanol; 60:15:25,
1.5 ml/min). Steroids were separated by HPLC using a C18
Figure 1 Glucocorticoid metabolic pathways. A is 11-dehydrocorticosterone; B is
corticosterone and HSD is hydroxysteroid dehydrogenase.
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Waters, Elstree, UK) at 35 8C and quantiﬁed byon-line liquid
scintillation counting.
Owing to the paucity of intra-abdominal adipose tissue in
lean mice, omental adipose tissue was used to quantify
enzyme activity, whereas mesenteric adipose was used to
quantify transcript abundance.
5b-Reductase activity assay
Hepatic 5b-reductase (5bR) activity was assessed by the
conversion of [
3H]4-corticosterone to [
3H]4-5b-tetrahydrocor-
ticosterone in hepatic cytosol (Livingstone et al. 2005). Enzyme
velocity was measured by incubating cytosol in duplicate at
37 8C, in sodium phosphate buffer (40 mmol/l Na2PO4,
320 mmol/l sucrose, 1 mmol/l dithiothreitol, pH 7.5)
containing NADPH (1 mmol/l), glucose-6-phosphate
(5 mmol/lM),glucose-6-phosphatedehydrogenase(1 unit/ml),
[
3H]4-corticosterone (10 nmol/l) and unlabelled corticosterone
(1.99 mmol/l; Livingstone et al. 2005). Protein concentration
and incubation period (0.5m g / m lf o r2 4h )w e r eo p t i m i s e d
to ensure ﬁrst order kinetics. Steroids were extracted with
ethyl acetate, the organic phase was evaporated under nitrogen
and extracts re-solubilised in mobile phase and analysed by
HPLC as above.
Quantiﬁcation of mRNA by real-time quantitative PCR
Total RNA was extracted from snap-frozen tissue samples,
and 500 ng reverse transcribed into cDNA with random
primers using the QuantiTect DNase/reverse transcription
kit (Qiagen Ltd). cDNA (equivalent to 10 ng total RNA)
was incubated in triplicate with 1! gene speciﬁc assay
mix (Applied Biosystems, Warrington, UK) in 1! Light-
Cycler480 Probes mastermix (Roche Diagnostics Ltd).
PCR cycling and detection of ﬂuorescent signal was carried
out using a Roche LightCycler480. A standard curve was
constructed for each primer probe set using a serial dilution
of cDNA pooled from all samples. For liver and adipose,
results were corrected for 18S and cyclophilin A RNA
respectively, which were not different between groups.
Assays used were: 11b-HSD1, Mm00476182_m1; 5aR1,
Mm00614213_m1; 5bR, Mm00520266_m1; 18S, Hs99999
901_s1 and Cyclophilin A, Mm02342430_g1.
Statistical analysis
Data are meanGS.E.M.a n dg r o u p s( nZ10–12 unless
otherwise stated) were compared by Student’s t-test.
Results
Both db/db mice and ob/ob mice were heavier than their
respective control groups at the time of cull (Table 1), and
had increased liver weight. Both db/db and ob/ob mice had
higher circulating glucose, insulin and corticosterone and
hepatic triglycerides than lean controls.
Hepatic glucocorticoid metabolism
Hepatic11b-HSD1activitywaslower inbothdb/dbandob/ob
mice compared with lean controls (Fig. 2A and B), although
mRNA for 11b-HSD1 was not different in either model
(Fig. 2E and F). 5bR activity and transcript abundance were
higher in both db/db and ob/ob mice compared with their
controls (Fig. 2C–F). There was no difference in abundance
of 5aR1 mRNA between lean and obese animals of either
strain (Fig. 2E and F). Activity of 5aR1 was not measured
due to instability of the protein (Eicheler et al. 1995).
Glucocorticoid metabolism in adipose tissue
In db/db mice, activity of 11b-HSD1 was higher in retro-
peritoneal and omental adipose but lower in s.c. and
epidydimal adipose compared with controls (Fig. 3A).
In ob/ob mice, 11b-HSD1 activity was higher in epididymal,
retro-peritoneal and omental adipose but lower in s.c. adipose
tissue compared with controls (Fig. 3B). Expression of
11b-HSD1 mRNA followed a similar pattern, in the main
(Fig. 3C and D), although dysregulation of 11b-HSD1
mRNA was not observed in epididymal adipose tissue. Note
that in mesenteric adipose tissue, limited amounts of tissue in
lean mice resulted in analysis of only nZ6 samples, and hence
borderline statistical signiﬁcance for the up-regulation of
abundance of 11b-HSD1 mRNA in db/db mice.
Abundance of mRNA for 5aR1 was lower in s.c. adipose
tissue from obese mice of both strains compared with their
respective controls, but was not altered in mesenteric,
Table 1 Body and liver weights and plasma biochemistry of mice
Db/? control db/db Ob/? control ob/ob
Weight at cull (g) 25.0G0.54 34.5G0.92* 25.7G0.46 42.1G0.55
†
Liver (g) 1.31G0.02 2.14G0.14* 1.41G0.08 3.79G0.04
†
Glucose (mg/dl) 223G14 550G68* 207G109 367G42
†
Insulin (pg/ml) 1.2G0.25 .5G0.9* 0.5G0.1 O12.8
†
Liver TAG (mmol/g) 34.7G3.5 728G178* 36.3G5.3 2287G130
†
Corticosterone (nM) 7.2G1.46 0 .3G19.5** 17.9G4.77 7 .4G16.0
†
Data are meanGS.E.M., compared by Student’s t-test. *P!0.005, **P!0.01 for db/db mice versus Db/? control.
†P!0.005 versus ob/ob mice versus Ob/?
control. NZ10–13/group. NB insulin concentrations in all ob/ob mice exceeded the maximum point of the assay. TAG, triglycerides.
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strain (Fig. 3E and F).
Neither 5b- nor 5a-reductase 2 mRNAs were detected in
adipose tissue.
Discussion
These studies demonstrate that mice with genetic obesity due
to either defective leptin secretion (ob/ob) or sensitivity
(db/db) have similar alterations in 11b-HSD1 and 5bRa s
Zucker obese rats (Livingstone et al. 2005). This includes
down-regulation of 11b-HSD1 in liver and up-regulation
in visceral adipose tissue depots, although in obese mice
11b-HSD1 was lower in s.c. adipose depots. By contrast with
Zucker rats (Livingstone et al. 2005), however, 5aR1
expression was not increased in liver of obese mice and was
decreased in s.c. adipose tissue. Strikingly, we did not ﬁnd
systematic differences between glucocorticoid metabolism in
leptin deﬁcient ob/ob mice and leptin-resistant db/db mice.
This contrasts with the previous reports suggesting up-regula-
tion of 11b-HSD1 in the liver of db/db mice (Liu et al. 2005,
Nakano et al. 2007), and suggests that enhanced signalling
through the short Ob-Ra splicevariant doesnot contributeto
Figure 2 Hepatic glucocorticoid metabolism.11b-HSD1 activity measured as velocityofformation
of product following incubation of [
3H]4-corticosterone with hepatic homogenate from (A) Db/?
control (open) or db/db mice (light striped); (B) Ob/? control (black) or ob/ob mice (dark striped).
5b-Reductase activity measured as velocity of formation of product following incubation of [
3H]4-
corticosterone with hepatic cytosol from (C) Db/? control or db/db mice; (D) Ob/? control or ob/ob
mice. Abundance of mRNAs for hepatic enzymes measured by real-time PCR (corrected for 18S as
a housekeeping gene and presented as a percentage of respective control group) in (E) Db/? control
or db/db mice; (F) Ob/? control mice or ob/ob mice. Data are meanGS.E.M.; nZ10–12/group;
*P!0.05; **P!0.01.
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Previously observed effects of leptin administration in vivo to
reverse changes in 11b-HSD1 in ob/ob mice (Liu et al. 2003)
may have been mediated indirectly through weight loss and
reversal of the metabolic phenotype, which inevitably follow
leptin replacement.
The pattern of dysregulation of glucocorticoid metab-
olism in obese rodents differs in some respects from that in
obese humans. In human adipose tissue, up-regulation of s.c.
11b-HSD1 is widely reported but 5aR1 is not altered (Wake
et al. 2007b) and alterations in visceral adipose 11b-HSD1 are
inconsistent (Walker & Andrew 2006). In human liver,
down-regulation of 11b-HSD1 and up-regulation of both
5aR1 and 5bR activity have been reported consistently
(Andrew et al. 1998, Fraser et al. 1999, Rask et al. 2001,
Tomlinson et al. 2008), and some of these hepatic changes
are paralleled here in mice and in our studies of obese
Zucker rats (Livingstone et al. 2000, 2005, Barat et al. 2007).
This species speciﬁcity provides a potential opportunity to
dissect mechanisms determining dysregulation of glucocorti-
coid metabolism in humans using comparative studies in
rodents. However, given limited knowledge of regulation of
expression of A-ring reductases, the mechanism of altered
A-ring reductase activity in obesity remains uncertain. 5bRi s
Figure 3 Glucocorticoid metabolism in adipose tissues. 11b-HSD1 activity measured as velocity of
formation of product following incubation of [
3H]4-corticosterone with homogenates of adipose
tissues from (A) Db/? control (open) or db/db mice (light striped); (B) Ob/? control (black) or ob/ob
mice (dark striped). Abundance of mRNA for 11b-HSD1 in adipose tissue depots measured by real-
time PCR (corrected for cyclophilin A as a housekeeping gene and presented as a percentage of
respective control group) in (C) Db/? control or db/db mice; (D) Ob/? control or ob/ob mice.
Abundance of mRNAs for 5a-R1 in adipose beds measured by real-time PCR (corrected for
cyclophilin A as a housekeeping gene and presented as a percentage of respective control group) in
(E) Db/? control or db/db mice; (F) Ob/? control or ob/ob mice. Subcut is s.c. adipose, Epi is
epididymal, R/P is retro-peritoneal and Mes is mesenteric. Data are meanGS.E.M.; nZ6–12/group;
*P!0.05; **P!0.01.
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2005), and in humans is selectively up-regulated in insulin
resistance associated with fatty liver (Westerbacka et al. 2003).
The murine models reported here had markedly fatty
liver, moreso than that induced with diet-induced obesity.
However, the severity of steatosis was more marked in the
ob/ob mice, whereas the activityof 5b-reductasewas increased
to a greater extent in db/db mice. The db/db mice
demonstrated partial insulin deﬁciency, and progression
towards hyperglycaemia, whereas the ob/ob mice maintained
near to normal glucose concentrations, albeit with higher
insulin. This perhaps implicates the elevated insulin con-
centrations themselves in the dysregulation of steroid
metabolism. The other potent regulators of 5bR identiﬁed to
date are androgens, which imprint permanent down-
regulationof5bRinliverfollowinginuteroexposure(Einarsson
& Gustafsson 1973, Gustafsson & Stenberg 1974, Jansson et al.
1985). In addition, withdrawal of androgens increases 5bR
(Barat et al. 2007). Hence, the observed up-regulation may
reﬂect the characteristic lowering of circulating androgens in
obesity (Whitaker et al. 1983, Zumoff et al. 1990).
Regarding the regulation of 5aR1, these data suggest that
the mechanism of dysregulation in human obesity is context
and/or species-speciﬁc and does not operate in ob/ob or db/db
mice. A caveat, however, is that protein levels or activity of
5aR1 might vary in the absence of changes in mRNA,
but this cannot be readily tested given the instability of the
hepatic 5aR1 protein ex vivo (Eicheler et al. 1995). Previous
reports in both humans and rats support the notion that
up-regulation of 5aR1 is secondary to the development of
insulin resistance/hyperinsulinaemia and is reversible on
treatment (Tsilchorozidou et al. 2003, Livingstone et al. 2005,
Tomlinson et al. 2008). IGF-1 has been suggested as the
principlecandidatefordysregulationofhepatic5aR1(Horton
et al. 1993). However, both mouse strains studied exhibit
profound insulin resistance and therefore this explanation may
be overly simplistic. Studies of 5aRs in mouse reproductive
physiology have highlighted a possible redundancy between
the two isozymes compared with other species (Mahendroo
et al. 1996, 2001), but this is unlikely to explain the differences
in 5aR1 dysregulation in obese mice, since the expression of
5aR2 was not detected in either liver or adipose tissue.
The few reports to date examining 5aR1 in adipose tissue
in humans and Zucker rats suggest that the abundance of
transcript is not altered by obesity in s.c. depots (Barat et al.
2007, Wake et al. 2007b). However, in both ob/ob and db/db
mice, 5aR1 mRNA was down-regulated selectively in s.c.
adipose, again highlighting the differences in regulation in this
enzyme between species. In contrast to Zucker rats, in which
5aR1 expression was increased in omental adipose tissue
(Barat et al. 2007), changes in mRNA expression were not
observed in the murine mesenteric depot, although the
greater omental depot was not studied as a direct comparison
due to a paucity of tissue in lean mice.
Regulation of 11b-HSD1 transcription has been studied
extensively but the basis for tissues-speciﬁc dysregulation in
obesity remains elusive. Species differences in regulation of
11b-HSD1 have been demonstrated, most recently in relation
to PPAR agonists (Hermanowski-Vosatka et al. 2000, Wake
et al. 2007a). Elevated circulating glucocorticoid levels, that
are much more striking in rodent than in human obesity, may
contribute since 11b-HSD1 is a glucocorticoid-responsive
gene (Low et al. 1994, Jamieson et al. 1995, Voice et al. 1996).
The striking observation in murine obesity in the present data
is the down-regulation of 11b-HSD1 in s.c. adipose tissue.
This has also been observed in diet-induced and in polygenic
obesity in mice (Morton et al. 2004, 2005). However in
humans, inhibition of 11b-HSD1 in s.c. adipose tissue has
become an attractive target for restricting glucocorticoid
action, with most groups agreeing, that in humans, there is
up-regulation of the enzyme in this depot (Paulmyer-Lacroix
et al. 2002, Lindsay et al. 2003, Wake et al. 2003). Of interest is
the observation that changes in 11b-HSD1 activity in both
obese models are more marked than changes in mRNA,
indeed in epididymal fat mRNA was not altered. This
discrepancy has been reported by ourselves (Morton et al.
2004) and others (Bujalska et al. 2005, Jang et al. 2006)
previously. The relationship between activity and abundance
of transcript appears most robust in s.c. adipose in humans
(Wake et al. 2003, Goedecke et al. 2006); discrepancies
existing at other sites and observed here may reﬂect an
additional level of control of 11b-HSD1 protein by
post-translational modiﬁcation, e.g. glycosylation (Opperman
et al. 1995). Another source of variation between species
and depots is the mixture of cell types. 11b-HSD1 is
expressed in macrophages as well as adipocytes (Gilmour et al.
2006). There is emerging evidence that some depots,
and some animal models are more susceptible to macro-
phage inﬁltration in the adipose tissue in obesity (Surmi &
Hasty 2008).
In conclusion, murine obesity is characterised by some but
not all of the changes in steroid metabolism that are observed
in human obesity. The consequences of disrupted glucocor-
ticoid metabolism in rodents may differ from those in humans,
since rodents also exhibit substantially elevated circulating
concentrations of corticosterone, contrasting with low to
normal circulating cortisol in human obesity (Phillips et al.
2000). Nevertheless, mice may provide useful models in
which to investigate dysregulation of 5bR and 11b-HSD1
but not 5aR1 in liver. None of these changes differ
substantially in micewith or without leptin signalling through
Ob-Ra. The pattern of dysregulation of metabolism in
adipose tissue is, however, subtly different between species,
offering the possibility that further comparative biology
studies may elucidate relevant mechanisms.
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